CCNU NEPHROTOXICITY FOLLOWING SUSTAINED REMISSION IN OAT CELL CARCINOMASILVER HKB; MORTON DL.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 2; PP. 226-227; BIBL. 4 REF.Article

SUGGESTIVE EVIDENCE FOR IN VIVO BINDING OF SPECIFIC ANTITUMOR ANTIBODIES OF HUMAN MELANOMAS = ARGUMENTS EN FAVEUR DE LA FIXATION IN VIVO DES ANTICORPS ANTITUMORAUX SPECIFIQUES DES MELANOMES HUMAINSGUPTA RK; MORTON DL.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 1; PP. 58-62; BIBL. 29REF.Article

GROWTH AND METASTASIS OF HUMAN MELANOMA XENOGRAFTS IN THE HAMSTER HOSTRICHMOND RE; MORTON DL.1979; J. NATION. CANCER INST.; USA; DA. 1979; VOL. 62; NO 4; PP. 761-763; BIBL. 10 REF.Article

STUDIES OF LYMPHOCYTE STIMULATION TO TUMOR-ASSOCIATED ANTIGEN. I: UPTAKE OF LYMPHOCYTE PROTEIN AND NUCLEIC ACID PRECURSORS IN RESPONSE TO AUTOLOGOUS AND ALLOGENEIC TUMOR-ASSOCIATED ANTIGEN SOLUBILIZED FROM HUMAN TUMORSROTH JA; MORTON DL.1979; CANCER IMMUNOL. IMMUNOTHERAPY; DEU; DA. 1979; VOL. 7; NO 1; PP. 19-23; BIBL. 18 REF.Article

TREATMENT OF METASTATIC DISEASESTORM FK; MORTON DL.1979; ADV. IN SURG.; USA; DA. 1979; VOL. 13; PP. 33-68; BIBL. 154 REF.Article

PULMONARY RESECTION FOR SARCOMA METASTASES.HOLMES EC; MORTON DL.1977; ORTHOP. CLIN. N. AMER.; U.S.A.; DA. 1977; VOL. 8; NO 4; PP. 805-810; BIBL. 11 REF.Article

DETECTION OF CANCER-ASSOCIATED ANTIGEN (S) IN URINE OF SARCOMA PATIENTSGUPTA RK; MORTON DL.1979; J. SURG. ONCOL.; USA; DA. 1979; VOL. 11; NO 1; PP. 65-74; BIBL. 17 REF.Article

DOUBLE-ANTIBODY METHOD AND THE PROTEIN-A-BEARING STAPHYLOCOCCUS AUREUS CELLS METHOD COMPARED FOR SEPARATING BOUND AND FREE ANTIGEN IN RADIOIMMUNOASSAYGUPTA RK; MORTON DL.1979; CLIN. CHEM.; USA; DA. 1979; VOL. 25; NO 5; PP. 752-756; BIBL. 13 REF.Article

ADJUVANT CHEMOIMMUNOTHERAPY IN ADVANCED LESIONS OF THE HEAD AND NECK.EILBER FR; MORTON DL.1976; AMER. J. ROENTGENOL.; U.S.A.; DA. 1976; VOL. 126; NO 5; PP. 1082-1087; BIBL. 18 REF.Article

TUMOR-SPECIFIC CELLULAR CYTOTOXICITY TO HUMAN SARCOMAS: EVIDENCE FOR A CELL-MEDIATED HOST IMMUNE RESPONSE TO A COMMON SARCOMA CELL-SURFACE ANTIGEN = CYTOTOXICITE CELLULAIRE SPECIFIQUE DE TUMEUR VIS-A-VIS DES SARCOMES HUMAINS: MISE EN EVIDENCE D'UNE REPONSE IMMUNITAIRE A MEDIATION CELLULAIRE DE L'HOTE A UN ANTIGENE COMMUN DE LA SURFACE DES CELLULES DES SARCOMESCOHEN AM; KETCHAM AS; MORTON DL et al.1973; J. NATION. CANCER INST.; U.S.A.; DA. 1973; VOL. 50; NO 3; PP. 585-589; BIBL. 25REF.Serial Issue

THE ROLE OF IMMUNOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH MALIGNANT MELANOMAGOODNIGHT JE JR; MORTON DL.1979; WORLD J. SURG.; DEU; DA. 1979; VOL. 3; NO 3; PP. 309-319; ABS. FRE; BIBL. 92 REF.Article

CLINICAL TRIALS OF IMMUNOTHERAPY: PRESENT STATUSMORTON DL; GOODNIGHT JE JR.1978; CANCER; USA; DA. 1978; VOL. 42; NO 5; PP. 2224-2233; BIBL. 69 REF.Article

IMMUNOTHERAPY FOR MALIGNANT DISEASE.GOODNIGHT JE JR; MORTON DL.1978; ANNU. REV. MED.; U.S.A.; DA. 1978; VOL. 29; PP. 231-283; BIBL. 10 P.Article

DECREASED CORRELATION BETWEEN THE AGAROSE LEUKOCYTE MIGRATION INHIBITION ASSAY AND DELAYED CUTANEOUS HYPERSENSITIVITY RESPONSE TO PURIFIED PROTEIN DERIVATIVE IN CANCER PATIENTS.CHEE DO; HOLMES EC; MORTON DL et al.1978; J. NATION. CANCER INST.; USA; DA. 1978; VOL. 60; NO 4; PP. 769-772; BIBL. 31 REF.Article

PRESENCE OF A CARCINOMA-ASSOCIATED ANTIGEN(S) IN THE SPENT CHEMICALLY DEFINED MEDIUM OF A HUMAN COLON CARCINOMA CELL LINECHEE DO; GUPTA RK; MORTON DL et al.1980; J. SURG. ONCOL.; USA; DA. 1980; VOL. 13; NO 1; PP. 45-51; BIBL. 19 REF.Article

LDH AND MELANOMA = LDH ET MELANOMEFINCK SJ; GIULIANO AE; MORTON DL et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 5; PP. 840-843; ABS. ENG; BIBL. 14 REF.; GRAPHArticle

ASSESSMENT OF IN VIVO EFFECTIVENESS OF TUMORICIDAL CHEMOTHERAPY AND RADIATION THERAPY BY SERIAL ANALYSIS OF TUMOR-ASSOCIATED URINARY ANTIGEN TITERS IN PATIENTS WITH SARCOMAHUTH JF; GUPTA RK; MORTON DL et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1037-1042; BIBL. 8 REF.Article

CLINICAL ASPECTS OF UNKNOWN PRIMARY MELANOMAGIULIANO AE; MOSELEY HS; MORTON DL et al.1980; ANN. SURG.; USA; DA. 1980; VOL. 191; NO 1; PP. 98-104; BIBL. 23 REF.Article

DETERMINATION OF INCIDENCE AND PARTIAL CHARACTERIZATION OF TUMOR-ASSOCIATED ANTIGENS FOUND IN THE URINE OF PATIENTS BEARING SOLID TUMORSROTE NS; GUPTA RK; MORTON DL et al.1980; INTERNATION. J. CANCER; CHE; DA. 1980; VOL. 26; NO 2; PP. 203-210; BIBL. 23 REF.Article

ONCOFETAL ANTIGEN: A TUMOR-ASSOCIATED FETAL ANTIGEN IMMUNOGENIC IN MANIRIE RF; GIULIANO AE; MORTON DL et al.1979; J. NATION. CANCER INST.; USA; DA. 1979; VOL. 63; NO 2; PP. 367-373; BIBL. 57 REF.Article

DISSEMINATED MELANOMA PRESENTING AS A CATASTROPHIC EVENTMOSELEY HS; NIZZE A; MORTON DL et al.1978; AVIAT. SPACE ENVIRONMENT. MED.; USA; DA. 1978; VOL. 49; NO 11; PP. 1342-1346; BIBL. 18 REF.Article

ANTIGENS ON HUMAN TUMOR CELLS ASSAYED BY COMPLEMENT FIXATION WITH ALLOGENEIC SERAGUPTA RK; IRIE RF; MORTON DL et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 8; PP. 2573-2580; BIBL. 42 REF.Article

DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS TO MELANOMA ANTIGEN. = REACTIONS D'HYPERSENSIBILITE CUTANEE TARDIVE A L'ANTIGENE DES MELANOMESHOLMES EC; ROTH JA; MORTON DL et al.1975; SURGERY; U.S.A.; DA. 1975; VOL. 78; NO 2; PP. 160-164; BIBL. 15 REF.Article

THE USE OF VIABLE FROZEN LYMPHOCYTES FOR STUDIES IN HUMAN TUMOR IMMUNOLOGYGOLUB SH; SULIT HL; MORTON DL et al.1975; TRANSPLANTATION; U.S.A.; DA. 1975; VOL. 19; NO 3; PP. 195-202; BIBL. 13REF.Serial Issue

PRODUCTION AND CHARACTERIZATION OF XENOGENEIC ANTISERA TO TUMOR-ASSOCIATED ANTIGEN(S)GUPTA RK; SILVER HKB; MORTON DL et al.1980; J. SURG. ONCOL.; USA; DA. 1980; VOL. 13; NO 1; PP. 75-89; BIBL. 2 P.Article